1. Ketamine’s mechanism of action: a path to rapid‐acting antidepressants;Abdallah;Depress. Anxiety,2016
2. Rapamycin, an immunosuppressant and mTORC1 inhibitor, triples the antidepressant response rate of ketamine at 2 weeks following treatment: a double-blind, placebo-controlled, cross-over, randomized clinical trial;Abdallah;Biorxiv,2018
3. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model;Abelaira;Neurosci. Res.,2013
4. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression;Acevedo-Diaz;J. Affect. Disord.,2019
5. New insight into the mechanisms of fast-acting antidepressants: what we learn from scopolamine;Anacker;Biol. Psychiatry,2018